Cleared Traditional

K932464 - PERIPHERALLYINSRTED VENOUS CATH. ALTERNATE CATH.

K932464 is an FDA 510(k) clearance for PERIPHERALLYINSRTED VENOUS CATH. ALTERN..., manufactured by Pharmacia Deltec, Inc.. The device is a Class 2 General Hospital device with product code LJS cleared through the Traditional 510(k) pathway after a 346-day FDA review.

K932464 · Pharmacia Deltec, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1994
Decision
346d
Days
Class 2
Risk

K932464 is an FDA 510(k) clearance for the PERIPHERALLYINSRTED VENOUS CATH. ALTERNATE CATH.. Classified as Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (product code LJS), Class II - Special Controls.

Submitted by Pharmacia Deltec, Inc. (St. Paul, US). The FDA issued a Cleared decision on May 2, 1994 after a review of 346 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5970 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Pharmacia Deltec, Inc. devices

FDA 510(k) Submission Details - K932464

510(k) Number K932464 FDA.gov
FDA Decision Cleared Substantially Equivalent - Special 510(k) (SESK)
Date Received May 21, 1993
Decision Date May 02, 1994
Days to Decision 346 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
217d slower than avg
Panel avg: 129d · This submission: 346d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJS Device Classification - Class 2, Special Controls

Product Code LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5970
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJS Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days

All 263
Devices cleared under the same product code (LJS) and FDA review panel - the closest regulatory comparables to K932464.
PROCEDURAL TRAY FOR PERIPHERALLY INSERTED VENOUS
K932211 · Pharmacia Deltec, Inc. · May 1994
DUAL LUMEN PERIPHERALLY INSERTED VENOUS CATHETER
K932430 · Pharmacia Deltec, Inc. · May 1994
PHERIPHERALLY INSERTED VENOUS CATHETER-Y SITE
K932433 · Pharmacia Deltec, Inc. · May 1994
ONECATH L-CATH CATHETER SYSTEM
K930473 · Luther Medical Products, Inc. · Apr 1994
ARROW PICC-PERIPHERALLY INSERTED CENTRAL CATHETER
K930129 · Arrow Intl., Inc. · Mar 1994
L CATH(R) CATHETER SYSTEM
K925236 · Luther Medical Products, Inc. · Mar 1994